
Reset all filters
01 1Stronger Neo-Minophagen C And Glycyron
02 1Stronger Neo-Minophagen C and Glycyron Tablets
03 1Stronger Neo-Minophagen C and Glycyron
Main Therapeutic Indication : Gastrointestinal Diseases
Currency : USD
2023 Revenue in Millions : 37
2022 Revenue in Millions : 70
Growth (%) : -41
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2017 Revenue in Millions : 95
2016 Revenue in Millions : 82
Growth (%) : 16
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2018 Revenue in Millions : 96
2017 Revenue in Millions : 89
Growth (%) : 8%